Prevalence of Candida albicans and Candida no albicans in clinical samples during 1999-2001;Prevalencia de Candida albicans y Candida no albicans en diferentes muestras clínicas. Período 1999-2001

Revista Argentina de Microbiologia

Volumn 36, Issue 3, 2004, Pages 107-112

  Mujica, M T ^a   Finquelievich, J L ^a   Jewtuchowicz, V ^a   Iovannitti, C A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Candida no albicans; Disk diffusion; Epidemiology surveillance; Fluconazole; Susceptibility

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA MEDIASTINISTIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; EMPIRICISM; FUNGAL DETECTION; FUNGUS ISOLATION; HOSPITAL PATIENT; MUCOSA; NONHUMAN; ONYCHOMYCOSIS; PREVALENCE; URINARY TRACT INFECTION; YEAST;

ANTIFUNGAL AGENTS; ARGENTINA; BODY FLUIDS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; CANDIDIASIS, CUTANEOUS; CANDIDIASIS, VULVOVAGINAL; CATHETERIZATION, PERIPHERAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; FUNGEMIA; HUMANS; MALE; MEDIASTINITIS; MUCOUS MEMBRANE; ONYCHOMYCOSIS; ORGAN SPECIFICITY; PREVALENCE; RETROSPECTIVE STUDIES; SPECIES SPECIFICITY; URINARY TRACT INFECTIONS;

EID: 8344222668     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Abid-Said D, Anaissie E, Uzun O, Raad I, Piazcowski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24: 1122-1128.
2. Aguirre Urizar JM (2002) Candidiasis orales Rev. Iberoam. Micol. 19: 17-21.
3. Bow JE, Loewen R, Cheang MS, Schater B (1995) Invasive fungal disease in adults undergoing remiss ion-induction therapy for acute myeloid leukemia: the pathogenic role of antileukemic regimen. Clin. Infect. Dis. 21: 361-369.
4. Calderone RA (2002) Taxonomy and biology of Candida. En: Calderone RA (Ed), Candida and candidiasis, ASM Press, Washington, p. 15-27.
5. Clancy CJ, Hong Nguyen M, Morris AJ (1997) Candidal mediastinitis: an emerging clinical entity. Clin. Infect. Dis. 25: 608-613.
6. Clark TA, Hajjeh RA (2002) Recent trends in the epidemiology of invasive mycoses. Curr. Opin. Infect. Dis. 15: 569-574.
7. Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, Pfaller MA (2002) Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J. Clin. Microbiol. 40: 1298-1302.
8. Douglas JL (2003) Candida biofilms and their role in infection. Trends Microbiol. 11: 30-36.
9. Fan-Harvard P, Capano D, Smith SM, Mangia A, Eng RH (1991) Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob. Agents Chemother. 35: 2302-2305.
10. Fidel PL, Vazquez JA, Sobel JD (1999) Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C.albicans. Clin. Microbiol. Rev. 12: 80-96.
11. Finquelievich JL, Iovannitti C, Mujica MT, Relloso S, Carnovale S, Elías Costa MR, Jewtuchowicz VM, Espinel-Ingroff A (2003) Susceptibility of Candida species to fluconazole assayed by a disk diffusion method with automated reading versus a microdilution method. Rev. Arg. Microbiol. 35: 214-218.
12. Gautret P, Rodier M.H, Kauffmann-Lacroix C, Jacquemin JL (2000) Case report and review. Onychomycosis due Candida parapsilosis. Mycoses 43: 433-435
13. Hazen KC (1995) New and emerging yeast pathogens. Clin. Microbiol. Rev. 8: 462-478.
14. Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 178: 792-802.
15. Jitaurong S, Klamsiri S, Pattararagron N (1993) Milk medium for germ tube and chlamidoconidia production by Candida. Mycophatologia 123: 95-98.
16. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, Mckinsey DS, Karchmer AW, Sugar AM, Kay Sharkey P, Wise GJ et al. (2000) Prospective multicenter surveillance study of funguria in hospitalized patients. Clin. Infect. Dis. 30: 14-18.
17. Komshian SV, Uwaydah AK, Sobel JD, Crane LR (1989) Funguemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev. infect. Dis. 11: 379-390.
18. Korting HC, Ollert M, Georgi A and Froschl M (1988) In vitro susceptibility and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 26: 2626-2631.
19. Lopez-Jodra O, Torres-Rodriguez JM (1999) Especies fúngicas poco comunes responsables de onicomicosis. Rev. Iberoam. Micol. 16: S11-S15.
20. Lundstrom T, Sobel J (2001) Nosocomial candiduria: a review. Clin. Infect. Dis 32: 1602-1607.
21. Luppetti A, Tavanti A, Davini P, Ghelardi E, Corsini V, Merusi I, Boldrini A, Campa M, Senesi S (2002). Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J. Clin. Microbiol. 40: 2363-2369.
22. Marcel-Senet J (1997) Risk factors and physiopathology of candidiasis. Rev. Iberoam. Micol. 14: 6-13.
23. McMullan R, McClurg R, Xu J, Moore JE, Millar BC, Crowe M, Hedderwick S (2002) Trends in the epidemiology of Candida bloodstream infections in Northern Ireland between January 1984 and December 2000. J. Infect. 45: 25-28.
24. Meis J, Petrou M, Billie J, Ellis D, Gibbs D. A global antifungal surveillance group (2000) A global evaluation of susceptibility of Candida species to fluconazole by disk diffusion. Diag. Microbiol. Infect. Dis. 36: 215-223.
25. National Committee for Clinical Laboratory Standards (2003) Method for antifungal disk diffusion susceptibility testing of yeasts; proposed guidelineM44-P. Vol 23 N° 6. NCCLS Villanova, PA.
26. Pfaller MA (1996) Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22 (Suppl 2): S89-S94.
27. Pfaller MA, Jones RD, Doern GV, Sader HS, Hollis RJ, Messer SA for the Sentry Participant Group (1998) International surveillance of bloodstream infections due to Candida species: frecuency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the Sentry Program. J. Clin. Microbiol. 36: 1886-1889.
28. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ the Sentry Participant Group (2000) Bloodsteam infections due to Candida species: Sentry antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob. Agents Chemother. 44: 747-751
29. Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ, the Sentry Participants Group (2002) Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: Sentry Antimicrobial Surveillance Program, 1997 to 2000. J. Clin. Microbiol. 40: 852-856.
30. Preeti NM, McNeil SA, Bradley SF, Kauffman CA (2002) Candida albicans sternal wound infections: a chronic and recurrent complication of median sternotomy. Clin. Infect. Dis. 35: 1316-1320.
31. Price MF, LaRocco MT, Gentry LO (1994) Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38: 1422-1424.
32. Rippon JW (1982) Medical Mycology. The pathogenic fungi and pathogenic Actinomycetes. W. B. Saunders Company Philadelphia, p.532-558.
33. Rodero L, Boutureira M, Demkura H, Burkett C, Fernández M, Losso M, Jauregui Rueda H, Monticelli A, Vitale R, Canteros C, Hochenfellner F, Vivot W, Davel G (1997). Infecciones por levaduras: agentes causales y su resistencia a antifúngicos en pacientes pediátricos hospitalizados y en adultos HIV positivos. Rev. Arg. Microbiol. 29: 7-15.
34. Rodero L, Davel G, Córdoba S, Soria M, Canteras C, Hochenfellner F participantes del grupo EMIFN (1999). Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina. Rev. Arg. Microbiol. 31: 114-119.
35. Safdar A, Perlin DS, Armstrong D (2002) Hematogenous infections due to Candida parapsilosis: changing trends in fungemics patients at a comprehensive cancer center during the last four decades. Diagn. Microbiol. Infect. Dis. 44: 11-16.
36. Sandven P (2000) Epidemiology of candidemia. Rev. Iberoam. Micol. 17: 73-81.
37. Saporiti AM, Gomez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L (2001) Candidiasis vaginal: etiología y perfil de sensibilidad a agentes antifúngicos de uso clinico. Rev. Arg. Microbiol. 33: 217-222.
38. Segal R, Kimchi A, Kritzman A, Inbar R, Segal Z (1999) The frequency of Candida parapsilosis in onychomycosis. An epidemiological survey in Israel. Mycoses 43: 349-353.
39. Sobel JD, Kauffman CA, McKinsey D, Zervos M, Vazquez JA, Karchmer AW, Lee J, Thomas C, Panzer H, Dismukes WE et al. (2000) Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. Clin. Infect. Dis. 30: 19-24.
40. Sturtevant J, Calderone R (1997) Candida albicans adhesins: biochemical aspects and virulence Rev. Iberoam. Micol. 14: 90-97.
41. Verduyn Lunel FM, Meis JFGM, Voss A (1999). Nosocomial fungal infections: candidemia. Diagn. Microbiol. Infect. Dis. 34: 213-220.
42. Zancopé-Oliveira RM, James MJ, Derossi AP, Sampaio JLM, Muniz MM, Li RK, Nascimento ASA, Peralta JM, Reiss E (2000) Strain characterization of Candida parapsilosis fungemia by molecular typing methods. Eur. J. Clin. Microbial. Infect. Dis. 19: 514-520.
43. Ziarrusta G B (2002) Vulvovaginitis candidiásica Rev. Iberoam. Micol. 19: 22-24.